Aim: Asenapine is a new atypical antipsychotic prescribed for the treatment of psychosis/bipolar disorders that presents higher affinity for serotonergic than dopaminergic receptors. The objective of this study was to investigate its antidepressant-like and antimanic-like properties on relevant animal models of depression and mania and to assess the acute and chronic effect of Asenapine on dorsal raphe nucleus (DRN) 5-HT cell firing activity.
and predictive validity to identify therapeutic interventions. Actually, the forced swimming test (FST) and amphetamine-induced hyperactivity test are the most popular paradigms to screen new antidepressant and antimanic candidates, respectively. 2 In the FST, Kitamura et al. 3 were the first to report that chronically administered ACTH (100 μg/d, s.c.), leading to sustained increase in plasmatic corticosterone, counteracts the decrease in the immobility time caused by classical antidepressants including the TCA imipramine, desipramine and the dual serotonin and noradrenaline reuptake inhibitor milnacipran. 3, 4 Remarkably, similar results are obtained after repeated electroconvulsive seizures and treatment with the dual norepinephrine and dopamine reuptake inhibitor buproprion. 5, 6 Kitamura et al. 5 proposed that animals chronically treated with ACTH can be a useful animal model of TCA treatment-resistant depression. 4, 5 Another relevant model of mania is the rapid eye movement (REM) sleep deprivation (SD) model, firstly proposed by Gessa et al., 7 that produces a transient episode of hyperactivity and insomnia, major clinical symptoms of manic episodes. Nonetheless, even if SD is a triggering factor of manic episodes in BD patients, 8 SD is less studied in the view of mania modeling. We suggest that SD should be investigated more deeply, particularly for its predictive validity, for the following reasons. Previous studies have
shown that both 96 hours and 72 hours of REM SD reduce hippocampal neurogenesis of adult rats 9,10 and because neuroplasticity deficits can be associated to BD, 11 the SD model might be more suitable in understanding neurobiological characteristics of mania and for screening new drugs. Several physiological functions, such as anxiety/affect or circadian rhythms/sleep, are influenced by 5-HT system. 12 The 5-HT 7 receptor, the most recently identified member of the 5-HT receptor family, 13 has been shown to be involved in several functions modulated by the 5-HT system such as circadian rhythms. 14,15 5-HT 7 receptor is located in the supra-chiasmatic nucleus of the hypothalamus, where it is intensely involved in circadian rhythm of animal activity. 16, 17 As poor circadian synchrony has been linked to maladaptive changes in bipolar depression, 18 one may assume that drugs that target key 5-HT ; however, it has been shown to act as a partial 5-HT 1A agonist when applied by microiontophoresis in both the DRN and hippocampus. 25 In view of these elements, this study was aimed, first, at investigating the antimanic-like and antidepressant-like actions of Asenapine behaviorally in validated manic and depressive models. 9, 27 Second, the effects of acute and sustained administration of Asenapine on the firing activity of DRN 5-HT neurons will be eval- 
| Drugs
Asenapine Because of the muscular atonia associated with the REM sleep onset, the rat fells into the water when the REM sleep starts. Similar previous studies showed that rats displayed a 30%-35% decrease in slow wave sleep and a 99% decrease in REM sleep. 32, 33 Food and water were available ad libitum, and the container was cleaned every day.
During cleaning time, animals were located 5 minutes in a dry cage in which they remained awake (grooming and exploratory behaviors).
Control rats were kept in their home cages (four rats per cage) during 
| ACTH model
ACTH ( 
| Electrophysiological experiments

| Chronic treatments
| Statistical analysis
Statistical analysis was performed using StatView (Abacus Concepts Inc., USA). We used two-way repeated-measures and one-way ANOVA followed by PLSD Fisher's post hoc test for electrophysiological experiments, two-way ANOVA followed by PLSD Fisher's post hoc test for behavioral studies. Statistical significance was set at P<.05.
| RESULTS
| Effects of Asenapine in the sleep deprivation (SD) model of mania
To assess the potential antimanic-like efficacy of Asenapine, we meas- PLSD post hoc analysis showed that Asenapine, at both doses tested, significantly decreased the hyperlocomotion of SD rats (P<.001).
Despite a trend toward a decreased locomotor activity, Asenapine did not significantly reduce the locomotion of control animals.
| Effects of Asenapine in the ACTH model of resistant depression
To evaluate the potential antidepressant-like activity of Asenapine, we 
| Effects of Asenapine and SB 269970 on 5-HT 7 receptor responsiveness of dorsal raphe (DR) serotoninergic (5-HT) neurons
In the present experiments, DR 5-HT neurons were identified on the basis of their firing discharge patterns, following previous criteria.
35,36
As expected, administration of cumulative doses of the 5- 
| Effects of sustained Asenapine administration on the spontaneous firing activity of DR 5-HT neurons
The mean spontaneous firing activity of DR 5-HT neurons in control rats was 0.99 ± 0.10 Hz (n=55 cells; Figure 4A ). 
| DISCUSSION
The results of the present study show that Asenapine behaved as a potent antimanic-like agent in the 72 h-SD model of mania. 7,9 Moreover, Current antimanic pharmacotherapy, using frequently a mood stabilizer such as lithium, remains unsatisfactory due to partial therapeutic efficacy. 44 Accordingly, the development of novel antimanic agents has been hindered by the deficiency of appropriate animal models. There is an urgent need for animal models that reproduce the oscillating characteristics of BD, and most of preclinical researches use distinct models to evaluate such a disorder, that is, either model of mania or depression. 45 Actually to test the efficacy of potential antimanic agents, the "goldstandard" rodent model of mania is the amphetamine-induced hyperactivity model. 46 Another relevant model of mania is the SD model that produces a transient episode of hyperactivity and insomnia. Therefore, we recently found that, firstly, SD animals display behavioral alterations corresponding to manic symptoms of BD. Secondly, the antimanic drugs (lithium and aripiprazole), but not a classical antidepressant (fluoxetine), yield rapid antimanic-like effects in SD rats. As mentioned above, Asenapine is pharmacologically characterized by its high affinity for serotoninergic and α 2 -adrenergic receptors, 
